Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): Comparison with NO donors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 6, 2012, Pages 641-650

  Chlopicki, Stefan ^a,b   Lomnicka, Magdalena ^a   Fedorowicz, Andrzej ^b   Grochal, Elzbieta ^a,b   Kramkowski, Karol ^c   Mogielnicki, Andrzej ^c   Buczko, Włodzimierz ^c   Motterlini, Roberto ^d  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^d FACULTÉ DE MÉDECINE   (France)

Author keywords

Co releasing molecule (CO RMs); Human platelets; NO donors; Platelet aggregation

Indexed keywords

ANTITHROMBOCYTIC AGENT; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 3; CARBON MONOXIDE RELEASING MOLECULE A1; GUANYLATE CYCLASE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA; WASHED HUMAN PLATELET;

BORANES; CARBON DIOXIDE; CARBONATES; CELLS, CULTURED; HUMANS; NITRIC OXIDE DONORS; ORGANOMETALLIC COMPOUNDS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 84862877450     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0732-4     Document Type: Article

References (41)

1. Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, Buelow R, Kupiec-Weglinski JW (2002) Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35:815-823 (Pubitemid 34258375)
2. Boczkowski J, Poderoso JJ, Motterlini R (2006) CO-metal interaction: vital signaling from a lethal gas. Trends Biochem Sci 31:614-621 (Pubitemid 44740399)
3. Born GV (1967) Possible mechanisms of platelet aggregation by ADP and of its inhibition. Thromb Diath Haemorrh Suppl 26:173-174
4. Brune B, Schmidt KU, Ullrich V (1990) Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 192:683-688 (Pubitemid 20316870)
5. Cardinal DC, Flower RJ (1980) The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 3:135-158 (Pubitemid 10052139)
6. Chlopicki S, Olszanecki R, Janiszewski M, Laurindo FR, Panz T, Miedzobrodzki J (2004) Functional role of NADPH oxidase in activation of platelets. Antioxid Redox Signal 6:691-698 (Pubitemid 38890785)
7. Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R (2006) Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovasc Res 71:393-401 (Pubitemid 43949260)
8. Christodoulides N, Durante W, Kroll MH, Schafer AI (1995) Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 91:2306-2309
9. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, Motterlini R (2003) Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93: e2-e8
10. Coceani F, Kelsey L, Seidlitz E, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Rabinovitch M, Ackerley C (1997) Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. Br J Pharmacol 120:599-608 (Pubitemid 27089407)
11. Foresti R, Motterlini R (1999) The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 31:459-475
12. Foresti R, Motterlini R (2010) Interaction of carbon monoxide with transition metals: evolutionary insights into drug target discovery. Curr Drug Targets 11:1595-1604
13. Foresti R, Hoque M, Bains S, Green CJ, Motterlini R (2003) Haem and nitric oxide: synergism in the modulation of the endothelial haem oxygenase-1 pathway. Biochem J 372:381-390 (Pubitemid 36723883)
14. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, Green CJ, Motterlini R (2004) Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142:453-460 (Pubitemid 38869858)
15. Friebe A, Mullershausen F, Smolenski A, Walter U, Schultz G, Koesling D (1998) YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol 54:962-967 (Pubitemid 29002038)
16. Furchgott RF, Jothianandan D (1991) Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28:52-61
17. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48:184-188
18. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, Dawn B, Motterlini R, Bolli R (2004) Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286:H1649-H1653 (Pubitemid 38525450)
19. Hoenicka M, Becker EM, Apeler H, Sirichoke T, Schroder H, Gerzer R, Stasch JP (1999) Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide. J Mol Med 77:14-23 (Pubitemid 29146177)
20. Hussain AS, Marks GS, Brien JF, Nakatsu K (1997) The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can J Physiol Pharmacol 75:1034-1037 (Pubitemid 27487963)
21. Lo Iacono L, Boczkowski J, Zini R, Salouage I, Berdeaux A, Motterlini R, Morin D (2011) A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic Biol Med 50:1556-1564
22. Jia L, Bonaventura C, Bonaventura J, Stamler JS (1996) S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380:221-226 (Pubitemid 26090643)
23. Johnson TR, Mann BE, Clark JE, Foresti R, Green CJ, Motterlini R (2003) Metal carbonyls: a new class of pharmaceuticals? Angew Chem Int Ed Engl 42:3722-3729 (Pubitemid 37047710)
24. Kalinowski L, Dobrucki LW, Szczepanska-Konkel M, Jankowski M, Martyniec L, Angielski S, Malinski T (2003) Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action. Circulation 107:2747-2752 (Pubitemid 36667251)
25. Maines MD, Kappas A (1977) Enzymatic oxidation of cobalt proto-porphyrin IX: observations on the mechanism of heme oxygenase action. Biochemistry 16:419-423 (Pubitemid 8036371)
26. Motterlini R (2007) Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans 35:1142-1146 (Pubitemid 350214248)
27. Motterlini R, Otterbein LE (2010) The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9:728-743
28. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ (2002) Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90:E17-E24
29. Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, Green CJ (2003) Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 9:2525-2539 (Pubitemid 37236371)
30. Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, Foresti R, Green CJ (2005) CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 19:284-286 (Pubitemid 40189283)
31. Otterbein LE, Bach FH, Alam J, Soares M, Tao LH, Wysk M, Davis RJ, Flavell RA, Choi AM (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422-428 (Pubitemid 30208159)
32. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, Soares MP (2003) Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9:183-190 (Pubitemid 36227720)
33. Radomski MW, Palmer RM, Read NG, Moncada S (1988) Isolation and washing of human platelets with nitric oxide. Thromb Res 50:537-546
34. Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, Motterlini R (2005) Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 145:800-810 (Pubitemid 41076287)
35. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J (1992) S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89:444-448
36. Stamler JS, Lamas S, Fang FC (2001) Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106:675-683 (Pubitemid 32900659)
37. Stone JR, Marletta MA (1998) Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem Biol 5:255-261 (Pubitemid 28259740)
38. Tenhunen R, Marver HS, Schmid R (1969) The enzymatic conversion of hemoglobin to bilirubin. Trans Assoc Am Physicians 82:363-371
39. Utz J, Ullrich V (1991) Carbon monoxide relaxes ileal smooth muscle through activation of guanylate cyclase. Biochem Pharmacol 41:1195-1201
40. Wang R, Wu L (1997) The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 272:8222-8226 (Pubitemid 27147775)
41. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, Lee PJ (2003) Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 278:1248-1258 (Pubitemid 36790808)